SHRC orders probe into clinical trial

Published: 21st March 2013 10:52 AM  |   Last Updated: 21st March 2013 10:52 AM   |  A+A-

Based on a complaint filed by a petitioner, the State Human Rights Commission (SHRC) has directed the Drug Controller of India, Director of Drug Control Administration of Andhra Pradesh, the assistant commissioner of Petbasheerabad and the district medical and health officer, Ranga Reddy to look into the issue of a clinical trial conducted by one Aizant Drug Research Solutions Pvt. Ltd, and submit a report by 10 June.

G Bhageshwar Reddy, a resident of Petbasheerabad approached the SHRC on Wednesday with the complaint that he had undertaken a clinical trial of drugs related to blood pressure after being promised a sum of `12,500 for the experiment. “I am facing financial problems and hence I decided to take up the trial. The mobilisers of the company contacted me and I was told that I’d have to take the drugs from March 14-18,” Reddy explained, adding that he was told that he would be paid on March 18.

Reddy claimed the drugs had resulted in frequent vomiting, and that he would feeling dizzy. “When I approached the company on Mar 18, the doctor brashly told me he wasn’t concerned. Later, I was thrown out,” he  said.

Stay up to date on all the latest Hyderabad news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp